Kenneth C Malcolm - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kenneth C Malcolm

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Science Translational Medicine|February 23, 2022

Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in <i>Mycobacterium abscessus</i>Juan Manuel Belardinelli, Deepshikha Verma, Wei Li, et al.

Cell|May 14, 2022

Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infectionJerry A Nick, Rebekah M Dedrick, Alice L Gray, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 13, 2025

Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP studyJerry A Nick, Stacey L Martiniano, Valerie K Lovell, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Science Translational Medicine|February 23, 2022

Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in <i>Mycobacterium abscessus</i>Juan Manuel Belardinelli, Deepshikha Verma, Wei Li, et al.

Cell|May 14, 2022

Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infectionJerry A Nick, Rebekah M Dedrick, Alice L Gray, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 13, 2025

Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP studyJerry A Nick, Stacey L Martiniano, Valerie K Lovell, et al.

Pageof 6